X-linked hypophosphatemia (XLH) is the prototypic disorder of renal phosphate wasting, and the most common form of heritable rickets. Physicians, patients, and support groups have all expressed concerns about the dearth of information about this disease and the lack of treatment guidelines, which frequently lead to missed diagnoses or mismanagement. This perspective addresses the recommendation by conferees for the dissemination of concise and accessible treatment guidelines for clinicians arising from the Advances in Rare Bone Diseases Scientific Conference held at the NIH in October 2008. We briefly review the clinical and pathophysiologic features of the disorder and offer this guide in response to the conference recommendation, based on our collective accumulated experience in the management of this complex disorder.



Polls results
1

On a scale of 1 to 10, rate how much this article will change your clinical practice?

NO change
BIG change
78% Article relates to my practice (11/14)
14% Article does not relate to my practice (2/14)
7% Undecided (1/14)
2

Will this article lead to more cost-effective healthcare?

50% Yes (7/14)
35% No (5/14)
14% Undecided (2/14)
3

Was this article biased? (commercial or personal)

7% Yes (1/14)
85% No (12/14)
7% Undecided (1/14)
4

What level of evidence do you think this article is?

0% Level 1 (0/14)
35% Level 2 (5/14)
7% Level 3 (1/14)
21% Level 4 (3/14)
35% Level 5 (5/14)